Advances diabetes and obesity programs with icovamenib demonstrating durable 52-Week Phase II data and with BMF-650, Biomea’s next-generation, oral small molecule glucagon-like peptide-1 (“GLP-1”) ...
Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...
An update from Fusion Finance Ltd ( ($IN:FUSION) ) is now available. Fusion Finance Limited has announced the closure of its trading window for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback